nach oben

Current Bladder Dysfunction Reports

Erschienen in:

01.12.2014 | Geriatric Bladder Dysfunction (G Ghoniem, Section Editor)

Role of Urodynamics in the Evaluation of Elderly Voiding Dysfunction

verfasst von: Ayman Mahdy, Gamal M. Ghoniem

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Voiding dysfunction is a common condition in the elderly that can affect both men and women. Due to the age-associated changes in the lower urinary tract, voiding dysfunction in the elderly is usually complex and multifactorial, necessitating more objective testing sometimes. In this chapter, we will focus on the role of urodynamics in the setting of voiding dysfunction in the elderly. The term voiding dysfunction will be used to refer both to storage and obstructive lower urinary tract symptoms.

Organization WH. World Health Report—health in the 21st century: a vision for all. Geneva. World Health Organization. 1998;1998.

Statistics. FIFoA-R. Older Americans 2008: key indicators of well-being. Washington, DC: Federal Interagency Forum on Aging- Related Statistics. 2008, Mar.

Centers for Disease C, Prevention. Trends in aging—United States and worldwide. MMWR Morbid Mortal Wkly Rep. 2003;52(6):101–4.

Drach GW. INTRODUCTION:AGAING . Premier of Geriatric Urology. 2013:107.

Patel R, Nitti V. Bladder outlet obstruction in women: prevalence, recognition, and management. Curr Urol Rep. 2001;2(5):379–87.PubMedCrossRef

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.PubMedCrossRef

7.•

Chung DE DB, Kurta J, et al. Detrusor underactivity is prevalent after radical prostatectomy: a urodynamic study including risk factors. Can Urol Assoc J. 2013;7:E33–7. A good sample size study that reports the urodynamic findings in 264 patients who received radical prostatectomy.PubMedCentral

Valentini FA, Robain G, Marti BG. Urodynamics in women from menopause to oldest age: what motive? What diagnosis? Int Braz J Urol: Off J Braz Soc Urol. 2011;37(1):100–7.CrossRef

Taylor 3rd JA, Kuchel GA. Detrusor underactivity: Clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr Soc. 2006;54(12):1920–32.PubMedCrossRef

10.

Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, et al. Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urol. 2012;53(5):342–8.PubMedCentralPubMedCrossRef

11.

Griffiths DJ, McCracken PN, Harrison GM, Gormley EA, Moore KN. Urge incontinence and impaired detrusor contractility in the elderly. Neurourol Urodyn. 2002;21(2):126–31.PubMedCrossRef

12.

Lewis JM, Yalla SV, Stanitski KE, Sullivan MP. Spectrum of urodynamic abnormalities and renal function changes in adult men with non-neurogenic urinary retention. Neurourol Urodyn. 2012;31(4):544–8.PubMedCrossRef

13.•

Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20. An important joint effort between the ICS and IUGA terminology committees and which provides the most recent update of the terminology in female lower urinary tract symptoms.PubMed

14.

Stewrt WF, Corey R, Herzog AR, et al. Prevalence of overactive bladder in women: results from the NOBLE program. Int Urogynecol J. 2001;12(3):S66.

15.

Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–76.PubMedCrossRef

16.•

Winters JC, Dmochowski RR, Goldman HB, Herndon CD, Kobashi KC, Kraus SR, et al. Urodynamic studies in adults: AUA/SUFU guideline. J Urol. 2012;188(6 Suppl):2464–72. The most recent guideline statement on the use of urodynamics in adults.PubMedCrossRef

17.

Kasturi S JW, and Smith, AL. Urologic Office Procedures. Premier of Geriatric Urology. 2013:17-31.

18.

Ghoniem GM, et al.: The value of the vagina pack test in large cystoceles. J Urol. 1994;152:931-934 8051758

19.

Albo ME, Richter HE, Brubaker L, Norton P, Kraus SR, Zimmern PE, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med. 2007;356(21):2143–55.PubMedCrossRef

20.

Richter HE, Albo ME, Zyczynski HM, Kenton K, Norton PA, Sirls LT, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;362(22):2066–76.PubMedCentralPubMedCrossRef

21.••

Nager CW BL, Litman HJ, Zyczynski HM, Varner RE, Amundsen C, et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med. 2012;66(21):1987–97. This is a multicenter randomized trial comparing the most commonly used sling procedures; transobturator and retropubic.CrossRef

22.••

Miller EA, Amundsen CL, Toh KL, Flynn BJ, Webster GD. Preoperative urodynamic evaluation may predict voiding dysfunction in women undergoing pubovaginal sling. J Urol. 2003;169(6):2234–7. A randomized multicenter, non-inferiority trial in women with non-complicated stress urinary incontinence that is clinically demonstrated. The study compared the outcomes after either preoperative office evaluation alone versus office evaluation and urodynamic tests.PubMedCrossRef

23.

Lemack GE, Krauss S, Litman H, FitzGerald MP, Chai T, Nager C, et al. Normal preoperative urodynamic testing does not predict voiding dysfunction after Burch colposuspension versus pubovaginal sling. J Urol. 2008;180(5):2076–80.PubMedCrossRef

24.

Wang AC, Chen MC. The correlation between preoperative voiding mechanism and surgical outcome of the tension-free vaginal tape procedure, with reference to quality of life. BJU Int. 2003;91(6):502–6.PubMedCrossRef

25.

Visco AG, Brubaker L, Nygaard I, Richter HE, Cundiff G, Fine P, et al. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(5):607–14.PubMedCentralPubMedCrossRef

26.

Araki I, Haneda Y, Mikami Y, Takeda M. Incontinence and detrusor dysfunction associated with pelvic organ prolapse: clinical value of preoperative urodynamic evaluation. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(11):1301–6.PubMedCrossRef

27.

Barry MJ, Fowler Jr FJ, Bin L, Pitts 3rd JC, Harris CJ, Mulley Jr AG. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol. 1997;157(1):10–4. discussion 4-5.PubMedCrossRef

28.

Schafer W. Urodynamics in benign prostatic hyperplasia (BPH). Arch Ital Urol, Androl: Organo Ufficiale Soc Ital Ecografia Urol Nefrol / Assoc Ric Urol. 1993;65(6):599–613.

29.

McConnell JD. Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia. Urology. 1994;44(2):156–8.PubMedCrossRef

30.

Kaplan SA. Update on the american urological association guidelines for the treatment of benign prostatic hyperplasia. Rev Urol. 2006;8 Suppl 4:S10–7.PubMedCentralPubMed

31.

Reynard JM, Yang Q, Donovan JL, Peters TJ, Schafer W, de la Rosette JJ, et al. The ICS-'BPH' Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol. 1998;82(5):619–23.PubMedCrossRef

32.

Dorflinger T, Frimodt-Moller PC, Bruskewitz RC, Jensen KM, Iversen P, Madsen PO. The significance of uninhibited detrusor contractions in prostatism. J Urol. 1985;133(5):819–21.PubMed

33.

Knutson T, Edlund C, Fall M, Dahlstrand C. BPH with coexisting overactive bladder dysfunction–an everyday urological dilemma. Neurourol Urodyn. 2001;20(3):237–47.PubMedCrossRef

34.

Wadie BS, el Ebrahim HE, Gomha MA. The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study. J Urol. 2002;168(1):132–4.PubMedCrossRef

35.

Neal DE, Ramsden PD, Sharples L, Smith A, Powell PH, Styles RA, et al. Outcome of elective prostatectomy. BMJ. 1989;299(6702):762–7.PubMedCentralPubMedCrossRef

36.

Sullivan MP, Yalla SV. Detrusor contractility and compliance characteristics in adult male patients with obstructive and nonobstructive voiding dysfunction. J Urol. 1996;155(6):1995–2000.PubMedCrossRef

37.

Madersbacher S, Pycha A, Klingler CH, Mian C, Djavan B, Stulnig T, et al. Interrelationships of bladder compliance with age, detrusor instability, and obstruction in elderly men with lower urinary tract symptoms. Neurourol Urodyn. 1999;18(1):3–15.PubMedCrossRef

38.

Leng WW, McGuire EJ. Obstructive uropathy induced bladder dysfunction can be reversible: bladder compliance measures before and after treatment. J Urol. 2003;169(2):563–6.PubMedCrossRef

39.

McNicholas TA KR, Lepor H. Evaluation and nonsurgical management of benign prostatic hyperplasia. Campbell-Walsh Urology. 2012;Tenth Edition(Chapter 92):2611-54.

40.

Lepor H, Nieder A, Feser J, O'Connell C, Dixon C. Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates. Urology. 1997;49(3):476–80.PubMedCrossRef

41.

Rossi C, Kortmann BB, Sonke GS, Floratos DL, Kiemeney LA, Wijkstra H, et al. Alpha-blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it. J Urol. 2001;165(1):38–41.PubMedCrossRef

42.

Van Venrooij GE, Van Melick HH, Eckhardt MD, Boon TA. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate. J Urol. 2002;168(2):605–9.PubMedCrossRef

43.

Abrams PH, Farrar DJ, Turner-Warwick RT, Whiteside CG, Feneley RC. The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol. 1979;121(5):640–2.PubMed

44.

Kuo HC, Tsai TC. The predictive value of urine flow rate and voiding pressure in the operative outcome of benign prostatic hypertrophy. Taiwan Yi Xue Hui Za Zhi J Formos Med Assoc. 1988;87(3):323–30.

45.

Ou R, Pan C, Chen H, Wu S, Wei X, Deng X, et al. Urodynamically diagnosed detrusor hypocontractility: should transurethral resection of the prostate be contraindicated? Int Urol Nephrol. 2012;44(1):35–9.PubMedCrossRef

46.•

Jani AB, Johnstone PA, Liauw SL, Master VA, Brawley OW. Age and grade trends in prostate cancer (1974–2003): a surveillance, epidemiology, and end results registry analysis. Am J Clin Oncol. 2008;31(4):375–8. Although of small sample size, the study develops a new concept that may encourage future research . Detrusor hypocontractility is used to be thought of as a contraindication for transurethral resection of the prostate (TURP). The study results showed some promising results in patients with detrusor hypocontractility who have undergone TURP.PubMedCrossRef

47.

Ries LAG MD, Krapcho M, et al. SEER cancer statistics review, 1975-2007. wwwseercancergov/csr/1975_2007/indexhtml2011 [accessed 060411]. 2011.

48.

Ficazzola MA, Nitti VW. The etiology of post-radical prostatectomy incontinence and correlation of symptoms with urodynamic findings. J Urol. 1998;160(4):1317–20.PubMedCrossRef

49.

Chao R, Mayo ME. Incontinence after radical prostatectomy: detrusor or sphincter causes. J Urol. 1995;154(1):16–8.PubMedCrossRef

50.

Hammerer P, Huland H. Urodynamic evaluation of changes in urinary control after radical retropubic prostatectomy. J Urol. 1997;157(1):233–6.PubMedCrossRef

51.

Fitzpatrick JM, Gardiner RA, Worth PH. The evaluation of 68 patients with post-prostatectomy incontinence. Br J Urol. 1979;51(6):552–5.PubMedCrossRef

52.

Foote J, Yun S, Leach GE. Postprostatectomy incontinence. Pathophysiology, evaluation, and management. Urol Clin N Am. 1991;18(2):229–41.

53.

Khan Z, Mieza M, Starer P, Singh VK. Post-prostatectomy incontinence. A urodynamic and fluoroscopic point of view. Urology. 1991;38(5):483–8.PubMedCrossRef

54.

Matsukawa Y, Hattori R, Komatsu T, Funahashi Y, Sassa N, Gotoh M. De novo detrusor underactivity after laparoscopic radical prostatectomy. Int J Urol: Off J Jap Urol Assoc. 2010;17(7):643–8.CrossRef

55.

Aboseif SR, Konety B, Schmidt RA, Goldfien SH, Tanagho EA, Narayan PA. Preoperative urodynamic evaluation: does it predict the degree of urinary continence after radical retropubic prostatectomy? Urol Int. 1994;53(2):68–73.PubMedCrossRef

56.

Leach GEYS. Post-prostatectomy incontinence: part II. The results of treatment based on urodynamic evaluation. Neurourol Urodyn. 1992;11:99–105.CrossRef

57.

Filocamo MT, Li Marzi V, Del Popolo G, Cecconi F, Marzocco M, Tosto A, et al. Effectiveness of early pelvic floor rehabilitation treatment for post-prostatectomy incontinence. Eur Urol. 2005;48(5):734–8.PubMedCrossRef

58.

Minervini R, Felipetto R, Morelli G, Fontana N, Pampaloni S, Notaro M, et al. Bladder instability and incontinence after radical prostatectomy. Biomed Pharmacother = Biomed Pharmacother. 1996;50(8):383–5.CrossRef

59.

Sasaki YKS, Shinno Y, et al. Time course of urodynamic characteristics following radical retropubic prostatectomy. Neurourol Urodyn. 1995;14:572–3.

60.

Catalona W, and Han, M Definitive therapy for localized prostate cancer: an overview. Campbell-Walsh Urology. 2012;Tenth edistion:2771-88.

61.

Tanaka N, Fujimoto K, Hirao Y, Asakawa I, Hasegawa M, Konishi N. Variations in international prostate symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer. Urology. 2009;74(2):407–11.PubMedCrossRef

62.

Blaivas JG, Weiss JP, Jones M. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer. BJU Int. 2006;98(6):1233–7. discussion 7.PubMedCrossRef

63.

Wehle MJ, Lisson SW, Buskirk SJ, Broderick GA, Young PR, Igel TC. Prediction of genitourinary tract morbidity after brachytherapy for prostate adenocarcinoma. Mayo Clin Proc. 2004;79(3):314–7.PubMedCrossRef

64.

Henderson A, Cahill D, Laing RW, Langley SE. (125)Iodine prostate brachytherapy: outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics. BJU Int. 2002;90(6):567–72.PubMedCrossRef

65.

Fishman IJ, Shabsigh R, Kaplan AL. Lower urinary tract dysfunction after radical hysterectomy for carcinoma of cervix. Urology. 1986;28(6):462–8.PubMedCrossRef

66.

Chen XJ, Song YY, Du KH, Yu J, Li Y, Lin CQ. Significance of urodynamic analysis in the patients with recent voiding dysfunction after radical hysterectomy. Zhonghua Zhong Liu Za Zhi [Chin J Oncol]. 2012;34(1):35–8.

67.

Katepratoom C, Manchana T, Amornwichet N. Lower urinary tract dysfunction and quality of life in cervical cancer survivors after concurrent chemoradiation versus radical hysterectomy. Int Urogynecol J. 2014;25(1):91–6.PubMedCrossRef

68.

Pannek J, Hilfiker R, Goecking K, Bersch U. Preoperative urodynamic assessment in patients with spinal cord lesions undergoing sphincterotomy: is success predictable? Urol Int. 2009;83(4):386–91.PubMedCrossRef

69.

Ockrim J, Laniado ME, Khoubehi B, Renzetti R, Finazzi Agro E, Carter SS, et al. Variability of detrusor overactivity on repeated filling cystometry in men with urge symptoms: comparison with spinal cord injury patients. BJU Int. 2005;95(4):587–90.PubMedCrossRef

70.

Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatr. 2001;71(5):600–6.PubMedCentralPubMedCrossRef

71.

Myers DL, Arya LA, Friedman JH. Is urinary incontinence different in women with Parkinson's disease? Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(3):188–91.PubMedCrossRef

72.

Sakakibara R, Fowler CJ, Hattori T, Hussain IF, Swinn MJ, Uchiyama T, et al. Pressure-flow study as an evaluating method of neurogenic urethral relaxation failure. J Auton Nerv Syst. 2000;80(1–2):85–8.PubMedCrossRef

73.

Khan Z, Starer P, Yang WC, Bhola A. Analysis of voiding disorders in patients with cerebrovascular accidents. Urology. 1990;35(3):265–70.PubMedCrossRef

74.

Fowler CJ. Neurological disorders of micturition and their treatment. Brain: A J Neurol. 1999;122(Pt 7):1213–31.CrossRef

75.

Nitti VW, Adler H, Combs AJ. The role of urodynamics in the evaluation of voiding dysfunction in men after cerebrovascular accident. J Urol. 1996;155(1):263–6.PubMedCrossRef

76.

Jones KW, Schoenberg HW. Comparison of the incidence of bladder hyperreflexia in patients with benign prostatic hypertrophy and age-matched female controls. J Urol. 1985;133(3):425–6.PubMed

77.

Natsume O. Detrusor contractility and overactive bladder in patients with cerebrovascular accident. Int J Urol: Off J Japa Urol Assoc. 2008;15(6):505–10. discussion 10.CrossRef

78.

de Groat WC. Integrative control of the lower urinary tract: preclinical perspective. Br J Pharmacol. 2006;147 Suppl 2:S25–40.PubMedCentralPubMedCrossRef

79.

Seki S, Igawa Y, Kaidoh K, Ishizuka O, Nishizawa O, Andersson KE. Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats. Neurourol Urodyn. 2001;20(1):105–13.PubMedCrossRef

80.

Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71(9):670–6.PubMedCentralPubMedCrossRef

81.

Staskin DS, Vardi Y, Siroky MB. Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control. J Urol. 1988;140(1):117–8.PubMed

82.

Roth B, Studer UE, Fowler CJ, Kessler TM. Benign prostatic obstruction and parkinson's disease—should transurethral resection of the prostate be avoided? J Urol. 2009;181(5):2209–13.PubMedCrossRef

83.

Skelly J, Flint AJ. Urinary incontinence associated with dementia. J Am Geriatr Soc. 1995;43(3):286–94.PubMed

84.

Yap P, Tan D. Urinary incontinence in dementia—a practical approach. Aust Fam Physician. 2006;35(4):237–41.PubMed

85.

Sakakibara R, Uchiyama T, Yamanishi T, Kishi M. Dementia and lower urinary dysfunction: with a reference to anticholinergic use in elderly population. Int J Urol: Off J Japan Urol Assoc. 2008;15(9):778–88.CrossRef

86.

Lee SH, Cho ST, Na HR, Ko SB, Park MH. Urinary incontinence in patients with Alzheimer's disease: relationship between symptom status and urodynamic diagnoses. Int J Urol: Off J Japan Urol Assoc. 2014;21(7):683–7.CrossRef

87.•

Boden SD, Davis DO, Dina TS, Patronas NJ, Wiesel SW. Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am Vol. 1990;72(3):403–8. One of the very few studies that research the urodynamics in patients with alzheimer dementia.

88.

Williams AL. CT diagnosis of degenerative disc disease. The bulging annulus. Radiol Clin N Am. 1983;21(2):289–300.PubMed

89.

Susset JG, Peters ND, Cohen SI, Ghoniem GM. Early detection of neurogenic bladder dysfunction caused by protruded lumbar disk. Urology. 1982;20(4):461–3.PubMedCrossRef

90.

Cheek WR, Anchondo H, Raso E, Scott B. Neurogenic bladder and the lumbar spine. Urology. 1973;2(1):30–3.PubMedCrossRef

91.

Schaumburg HH, Berger, A.R., Thomas, P.K. Disorders of perepheral nerves. 1992;2nd edn(Philadelphia: FA Davis).

92.

Starer P, Libow L. Cystometric evaluation of bladder dysfunction in elderly diabetic patients. Arch Intern Med. 1990;150(4):810–3.PubMedCrossRef

93.

Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995;153(2):342–4.PubMedCrossRef

94.

Giannantoni A, Silvestro D, Siracusano S, Azicnuda E, D'Ippolito M, Rigon J, et al. Urologic dysfunction and neurologic outcome in coma survivors after severe traumatic brain injury in the postacute and chronic phase. Arch Phys Med Rehab. 2011;92(7):1134–8.CrossRef

95.

Campbell VA, Crews JE, Moriarty DG, Zack MM, Blackman DK. Surveillance for sensory impairment, activity limitation, and health-related quality of life among older adults—United States, 1993–1997. MMWR CDC surveillance summaries. Morb Mortal Wkly Rep CDC Surveill Summ / Centers Dis Control. 1999;48(8):131–56.

96.

Hill S, Elhilali M, Millard RJ, Dwyer PL, Lheritier K, Kawakami FT, et al. Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study. Curr Med Res Opin. 2007;23(11):2697–704.PubMedCrossRef

97.

Macdiarmid SA. Concomitant medications and possible side effects of antimuscarinic agents. Rev Urol. 2008;10(2):92–8.PubMedCentralPubMed

98.

Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am Vol. 2005;87(7):1487–97.CrossRef

99.

Haylen BT, Parys BT, Anyaegbunam WI, Ashby D, West CR. Urine flow rates in male and female urodynamic patients compared with the Liverpool nomograms. Br J Urol. 1990;65(5):483–7.PubMedCrossRef

100.

Abram P. Urodynamic techinques. In: Abram P, editor. Urodynamics. 3rd ed. Bristol: Springer; 2005. p. p. 17–116.

Titel: Role of Urodynamics in the Evaluation of Elderly Voiding Dysfunction
verfasst von: Ayman Mahdy
Gamal M. Ghoniem
Publikationsdatum: 01.12.2014
Verlag: Springer US
Erschienen in: Current Bladder Dysfunction Reports / Ausgabe 4/2014
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-014-0261-8

Neu im Fachgebiet Urologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Management of Overactive Bladder Refractory to Medical Therapy

Medical Therapy in Overactive Bladder of the Elderly

Long-Term Enterocystoplasty Follow-Up: Metabolic and Neoplastic Concerns

Lower Urinary Tract Dysfunction in Childhood: What’s Really Wrong with These Children?